Article
The impact of p53 status on cellular sensitivity to antifolate drugs.
Clinical cancer research : an official journal of the American Association for Cancer Research - 1 Jul 2001
Lu X, Errington J, Curtin N J, Lunec J, Newell D R
Abstract excerpt
The impact of p53 status on cellular sensitivity to antifolate drugs has been examined in seven human cell lines (A549, MCF7, T-47D, CCRF-CEM, COR-L23, A2780, and HCT-116) and p53 nonfunctional counterparts of two of the cell lines (HCT-116/N7 and A2780/CP70). p53 status was determined by sequencing and functional assays. The sensitivities of the cell lines to growth inhibition (sulphorhodamine B assay) produced...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
